Cloud Defense Logo

Products

Solutions

Company

Book A Live Demo

CVE-2018-14787 : Vulnerability Insights and Analysis

Discover the security impact of CVE-2018-14787 affecting Philips' IntelliSpace Cardiovascular products. Learn about the vulnerability, affected versions, and mitigation steps.

This CVE-2018-14787 article provides insights into a security vulnerability affecting Philips' IntelliSpace Cardiovascular (ISCV) products and Xcelera versions, potentially allowing unauthorized code execution.

Understanding CVE-2018-14787

This CVE involves improper privilege management in Philips' ISCV products, enabling attackers to access directories with executable files and run unauthorized code with local administrative privileges.

What is CVE-2018-14787?

An unauthorized individual with elevated privileges in Philips' ISCV products and Xcelera versions could exploit this vulnerability to access directories storing executable files, potentially leading to unauthorized code execution.

The Impact of CVE-2018-14787

The vulnerability could allow attackers to execute arbitrary code with local administrative permissions, posing a significant security risk to affected systems.

Technical Details of CVE-2018-14787

This section delves into the technical aspects of the CVE, including the vulnerability description, affected systems, and exploitation mechanism.

Vulnerability Description

The flaw in Philips' ISCV products and Xcelera versions allows attackers with escalated privileges to access folders containing executables, enabling them to execute unauthorized code with local administrative permissions.

Affected Systems and Versions

        Products: IntelliSpace Cardiovascular (ISCV) products
        Vendor: Philips
        Vulnerable Versions:
              IntelliSpace Cardiovascular, Version 3.1 or prior
              Xcelera Version 4.1 or prior

Exploitation Mechanism

Attackers with higher privileges can exploit the vulnerability to access directories storing executable files, leveraging authenticated users' write permissions to run unauthorized code with local administrative privileges.

Mitigation and Prevention

To address CVE-2018-14787, users and organizations should take immediate steps and implement long-term security practices to mitigate risks and enhance system security.

Immediate Steps to Take

        Update to the latest patched versions of ISCV products and Xcelera to mitigate the vulnerability.
        Restrict access to critical directories and files to authorized personnel only.
        Monitor system logs for any suspicious activities or unauthorized access attempts.

Long-Term Security Practices

        Conduct regular security audits and vulnerability assessments to identify and address potential weaknesses.
        Educate users on best practices for system access and privilege management.
        Implement robust access control measures to limit privileges based on job roles and responsibilities.

Patching and Updates

        Regularly apply security patches and updates provided by Philips to address known vulnerabilities and enhance system security.

Popular CVEs

CVE Id

Published Date

Is your System Free of Underlying Vulnerabilities?
Find Out Now